The expressions of 5-LOX mRNA and COX-2 mRNA in pancreatic cancer and their clinical significance
Author:
Affiliation:

Clc Number:

R735.9;Q58

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Abstract:Objective:To investigate the expression of 5-LOX in pancreatic cancer tissue and the relationship between expression of 5-LOX and COX-2. Methods:The expression of 5-LOXmRNA and COX-2mRNA in 35 fresh pancreatic cancer tissue samples were detected by semi-quantitive reverse transcriptase-polymerase chain reaction method. Results:Expression of 5-LOX mRNA and COX-2mRNA in pancreatic cancer tissue was 74.3%, 80%, respectively. Expressions of 5-LOX mRNA and COX-2 mRNA were not coordinated(P>0.05). There was correlation between the expression of 5-LOX and TNM stages. The expression of 5-LOX in stages III~IV of pancreatic cancer was markedly higher than that in stages I~II of pancreatic cancer(P<0.05). Conclusions:Expression of 5-LOX and COX-2 in pancreatic cancer tissue was markedly elevated, and correlated with clinical stage. Expressions of 5-LOX and COX-2 in pancreatic cancer were not coordinated.

    Reference
    Related
    Cited by
Get Citation

LU Li-hong, ZHANG Bo, ZENG Qing-dong, XU Xia.The expressions of 5-LOX mRNA and COX-2 mRNA in pancreatic cancer and their clinical significance[J]. Chin J Gen Surg,2006,15(6):7-422.
DOI:10.7659/j. issn.1005-6947.2006.06.007

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,1900
  • Revised:January 01,1900
  • Adopted:
  • Online: June 25,2006
  • Published: